What Women Need to Know about Essure
Marlo Thomas and Erin Brockovich, neither strangers to standing for a good cause, team up to explain what women need to know about Essure. It’s a brief, but enlightening interview.
Jay W. Belle Isle
Before becoming LegalReader's Editor-in-Chief, Jay W. Belle Isle worked as a freelance copywriter with clients on four continents. Jay has a degree in Business Administration from Cleary University and a Juris Doctor from Thomas M. Cooley Law School. Jay has also worked as a contracts administrator for a DOD contractor specializing in vehicle armor.
Essure Placement Rate Failure
Essure “permanent” birth control has an unacceptably high rate of placement failure, even when done by those with experience. Yet, the product was approved and this information was buried. Improper placement can result in organ perforation, among other things, and require surgery to remove the device.
Praxbind is the Pradaxa Antidote
The FDA granted fast track approval to Boeheringer’s latest drug offering, Praxbind. This new drug is the long-awaited antidote to new gen anticoagulant, Pradaxa. Preliminary clinical trials suggest an 89% efficacy rate within four hours of IV administration. This could be a life-saving tool for medical providers caring for patients on Pradaxa, a drug known for its high risk of uncontrollable and even fatal belleding events.
Surprise! You’re Pregnant! When Essure Doesn’t Work
The failure rate of “permanent” birth control implant, Essure, is several times that which is advertised by Bayer, its maker. In fact, it is several times that of tubal ligation, the surgical procedure Essure was meant to replace.
Why Suing Big Pharma Isn’t Changing Anything
Despite hundreds of lawsuits and mind-bogglingly huge settlements, Big Pharma doesn’t seem inclined to clean up its act and produce drugs that are actually safe. None of the current activities seem to matter to the industry. Here’s a look at why suing Big Pharma isn’t changing anything.
A Call to Arms: OB/GYN Speaks Out Against Essure
Dr. Julio Novoa, OG/GYN, takes a moment to detail Bayer’s untrustworthy “profits over patients” history as well as provide data on the Essure implantable “permanent” birth control device. The video explains the massive campaign of untruth maintained by Bayer regarding the safety and efficacy of the Essure product.
“If I don’t survive…” An Essure Victim Speaks Out
Brandi Casey, a former model and Essure victim, bravely speaks out about her experience with this dangerous medical device. She suffers from metal toxicity and a host of other adverse effects caused by Essure. Yet it’s maker, Bayer, and the FDA continue to tout it as a safe product.
POGO Says FDA’s Pradaxa Review was “Lax” and “Permissive”
An independent watchdog group, the Project on Government Oversight (POGO), found that the FDA’s approval of anti-coagulant drug Pradaxa was flawed. The POGO report details many poor decisions and conflicts of interest on the FDA’s part as it gave Boehringer, Pradaxa’s maker, several accommodations.
Black Coffee Drinkers are More Likely to be Psychopaths
Researchers discovered that there may be a link between favoring bitter tastes, such as black coffee, and less-than-positive personality traits. In fact, the study showed that those who prefer black coffee are more likely to be vain, manipulative, selfish, sadistic and even psychopathic.
Did Bayer Lie About Essure?
Bayer may have tampered with data from clinical trials and patient surveys pertaining to adverse effects caused by its Essure “permanent” birth control product. Patient surveys were altered, eliminating some valuable patient feedback. An advisory panel to the FDA met in late September to discuss Essure’s safety.